[Results of two new drugs in Parkinson's disease: L-dopa and amantadine].
D000328:Adult; D000368:Aged; D000547:Amantadine / Q000009:adverse effects / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004295:Dihydroxyphenylalanine / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D008875:Middle Aged; D010300:Parkinson Disease / Q000188:drug therapy*; D010301:Parkinson Disease, Postencephalitic / Q000188:drug therapy
D004295:Dihydroxyphenylalanine; D000547:Amantadine
Résultats de deux nouvelles thérapeutiques de la maladie de Parkinson : la L-dopa et l'amantadine.